2025年Immuno-Oncology Summit上領先製藥公司和創新生物技術公司的簡報演講

行業先驅、思想領袖和影響者的演講將介紹免疫腫瘤學領域的最新突破。

---

Engineering Antibody-Drug Conjugates for Optimal Payload Delivery in Solid Tumors
Ian Nessler, PhD, Senior Scientist II, Quantitative, Translational, and ADME Sciences, AbbVie

Functional Effects of Cancer Cell Phagocytosis on Tumor Macrophages
Kristin V. Tarbell, PhD, Associate Director, Discovery, Amgen

Women in Science Meet-Up
Amina Metidji, PhD, Senior Scientist, AstraZeneca

Advancing Drug Discovery with Hypoxic 3D Tumor Models
Orna Rabinovich Ernst, PhD, Senior Scientist, R&D, AstraZeneca

Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T Cell Exclusion in Human Lung Tumors
Shilpa Keerthivasan, PhD, Associate Director, Immunology, Bristol Myers Squibb

Comparison of Cancer-Targeting and Stromal-Targeting Antibody-Drug Conjugates Using Bystander Quantitative Systems Pharmacology Models
Ezgi Wood, PhD, Associate Director, QSP, Bristol Myers Squibb

Impacts of ADCs on the Immune Response to Cancer
Ryan A. Heiser, PhD, Director Immuno-Oncology, Pfizer

* 活動內容有可能不事先告知作更動及調整。